Apyx Medical (APYX) Total Non-Current Liabilities (2010 - 2026)

Apyx Medical (APYX) has 17 years of Total Non-Current Liabilities data on file, last reported at $49.6 million in Q1 2026.

• Quarterly Total Non-Current Liabilities rose 0.71% year-over-year to $49.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.6 million (up 0.71% YoY) and the FY2025 annual result came in at $51.7 million, up 2.81% from the prior year.
• Total Non-Current Liabilities slipped to $49.6 million in Q1 2026, from $51.7 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $52.1 million in Q4 2023 to a low of $12.9 million in Q3 2022.
• A 5-year average of $37.0 million and a median of $49.3 million in 2024 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2022 — Total Non-Current Liabilities retreated 5.12% — and 2023, when it surged 277.65%.
• Tracing APYX's Total Non-Current Liabilities over 5 years: stood at $13.8 million in 2022, then surged by 277.65% to $52.1 million in 2023, then slipped by 3.59% to $50.2 million in 2024, then advanced by 2.81% to $51.7 million in 2025, then retreated by 4.0% to $49.6 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $49.6 million (Q1 2026), $51.7 million (Q4 2025), and $51.0 million (Q3 2025), per Business Quant data.